UnitedHealth’s CEO Stephen Hemsley faces investor scrutiny over soaring medical costs and the withdrawal of the company’s 2025 earnings forecast. Stock has plunged over 40% this year. Hemsley promises to rebuild trust amid federal investigations into Medicare billing practices. Analysts expect a profit of $4.48 per share for the second quarter.

UnitedHealth plans to reset its 2025 profit forecast to $18-$20 per share, below the previous outlook of $26-$26.50. Investors warn that withholding guidance altogether would be damaging. The company faces reputational challenges and concerns about its Optum unit. A major cyberattack disrupted claims processing last year.

Read more at Yahoo Finance: UnitedHealth investors may seek roadmap on costs as Hemsley takes center stage